AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
AN EVALUATION OF THE INTERACTION OF MELOXICAM WITH FRUSEMIDE IN PATIENTS WITH COMPENSATED CHRONIC CARDIAC-FAILURE
Authors: MULLER FO MIDDLE MV SCHALL R TERBLANCHE J HUNDT HKL GROENEWOUD G
Citation: Fo. Muller et al., AN EVALUATION OF THE INTERACTION OF MELOXICAM WITH FRUSEMIDE IN PATIENTS WITH COMPENSATED CHRONIC CARDIAC-FAILURE, British journal of clinical pharmacology, 44(4), 1997, pp. 393-398
NO INTERACTION BETWEEN MELOXICAM AND FUROSEMIDE IN CARDIAC-FAILURE
Authors: MULLER FO MIDDLE MV SCHALL R TERBLANCHE J HUNDT HKL GROENEWOUD G
Citation: Fo. Muller et al., NO INTERACTION BETWEEN MELOXICAM AND FUROSEMIDE IN CARDIAC-FAILURE, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 100-100
EFFECT OF IPSAPIRONE ON PLASMA-GLUCOSE AND PHARMACOKINETICS OF IPSAPIRONE IN TYPE-I DIABETICS
Authors: LUUS HG MULLER FO GROENEWOUD G HUNDT HKL SCHALL R VANDYK M
Citation: Hg. Luus et al., EFFECT OF IPSAPIRONE ON PLASMA-GLUCOSE AND PHARMACOKINETICS OF IPSAPIRONE IN TYPE-I DIABETICS, Clinical drug investigation, 11(3), 1996, pp. 159-166
NO INFLUENCE OF PANTOPRAZOLE ON THE PHARMACOKINETICS OF PHENYTOIN
Authors: MIDDLE MV MULLER FO SCHALL R GROENEWOUD G HUNDT HKL HUBER R BLIESATH H STEINIJANS VW
Citation: Mv. Middle et al., NO INFLUENCE OF PANTOPRAZOLE ON THE PHARMACOKINETICS OF PHENYTOIN, International journal of clinical pharmacology and therapeutics, 34, 1996, pp. 72-75
RELATIVE BIOAVAILABILITY OF 4 CLOMIPRAMINE HYDROCHLORIDE TABLET PRODUCTS
Authors: MULLER FO SCHALL R MOGILNICKA EM GROENEWOUD G HUNDT HKL LUUS HG MIDDLE MV SWART KJ DEVAAL AC
Citation: Fo. Muller et al., RELATIVE BIOAVAILABILITY OF 4 CLOMIPRAMINE HYDROCHLORIDE TABLET PRODUCTS, Biopharmaceutics & drug disposition, 17(1), 1996, pp. 81-90
BIOAVAILABILITY OF 2 SELEGILINE HYDROCHLORIDE TABLET PRODUCTS
Authors: MULLER FO SCHALL R HUNDT HKL JOUBERT A MIDDLE MV MUIR AR DUURSEMA L GROENEWOUD G SWART KJ
Citation: Fo. Muller et al., BIOAVAILABILITY OF 2 SELEGILINE HYDROCHLORIDE TABLET PRODUCTS, Arzneimittel-Forschung, 46(11), 1996, pp. 1037-1040
STUDY OF THE EFFECT OF MIGLITOL ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF WARFARIN IN HEALTHY-MALES
Authors: SCHALL R MULLER FO HUNDT HKL DUURSEMA L GROENEWOUD G MIDDLE MV
Citation: R. Schall et al., STUDY OF THE EFFECT OF MIGLITOL ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF WARFARIN IN HEALTHY-MALES, Arzneimittel-Forschung, 46(1), 1996, pp. 41-46
EFFECT OF PANTOPRAZOLE ON OVULATION SUPPRESSION BY A LOW-DOSE HORMONAL CONTRACEPTIVE
Authors: MIDDLE MV MULLER FO SCHALL R HUNDT HKL MOGILNICKA EM BENEKE PC
Citation: Mv. Middle et al., EFFECT OF PANTOPRAZOLE ON OVULATION SUPPRESSION BY A LOW-DOSE HORMONAL CONTRACEPTIVE, Clinical drug investigation, 9(1), 1995, pp. 54-56
NO INFLUENCE OF PANTOPRAZOLE ON THE PHARMACOKINETICS OF PHENYTOIN
Authors: MIDDLE MV MULLER FO SCHALL R GROENEWOUD G HUNDT HKL HUBER R BLIESATH H STEINIJANS VW
Citation: Mv. Middle et al., NO INFLUENCE OF PANTOPRAZOLE ON THE PHARMACOKINETICS OF PHENYTOIN, International journal of clinical pharmacology and therapeutics, 33(5), 1995, pp. 304-307
LACK OF EFFECT OF PANTOPRAZOLE ON THE PHARMACODYNAMICS AND PHARMACOKINETICS OF WARFARIN
Authors: DUURSEMA L MULLER FO SCHALL R MIDDLE MV HUNDT HKL GROENEWOUD G STEINIJANS VW BLIESATH H
Citation: L. Duursema et al., LACK OF EFFECT OF PANTOPRAZOLE ON THE PHARMACODYNAMICS AND PHARMACOKINETICS OF WARFARIN, British journal of clinical pharmacology, 39(6), 1995, pp. 700-703
THE EFFECT OF FASTING ON TOTAL SERUM BILIRUBIN CONCENTRATIONS
Authors: MEYER BH SCHOLTZ HE SCHALL R MULLER FO HUNDT HKL MAREE JS
Citation: Bh. Meyer et al., THE EFFECT OF FASTING ON TOTAL SERUM BILIRUBIN CONCENTRATIONS, British journal of clinical pharmacology, 39(2), 1995, pp. 169-171
NO PHARMACOKINETIC OR PHARMACODYNAMIC INTERACTION BETWEEN RIVASTATIN AND WARFARIN
Authors: SCHALL R MULLER FO HUNDT HKL RITTER W DUURSEMA L GROENEWOUD G MIDDLE MV
Citation: R. Schall et al., NO PHARMACOKINETIC OR PHARMACODYNAMIC INTERACTION BETWEEN RIVASTATIN AND WARFARIN, Journal of clinical pharmacology, 35(3), 1995, pp. 306-313
INFLUENCE OF MELOXICAM ON FUROSEMIDE PHARMACOKINETICS AND PHARMACODYNAMICS IN HEALTHY-VOLUNTEERS
Authors: MULLER FO SCHALL R DEVAAL AC GROENEWOUD G HUNDT HKL MIDDLE MV
Citation: Fo. Muller et al., INFLUENCE OF MELOXICAM ON FUROSEMIDE PHARMACOKINETICS AND PHARMACODYNAMICS IN HEALTHY-VOLUNTEERS, European Journal of Clinical Pharmacology, 48(3-4), 1995, pp. 247-251
RELATIVE BIOAVAILABILITY OF RIFAMPICIN, ISONIAZID AND ETHAMBUTOL FROMA COMBINATION TABLET VS CONCOMITANT ADMINISTRATION OF A CAPSULE CONTAINING RIFAMPICIN AND A TABLET CONTAINING ISONIAZID AND ETHAMBUTOL
Authors: SCHALL R MULLER FO DUURSEMA L GROENEWOUD G HUNDT HKL MIDDLE MV MOGILNICKA EM SWART KJ
Citation: R. Schall et al., RELATIVE BIOAVAILABILITY OF RIFAMPICIN, ISONIAZID AND ETHAMBUTOL FROMA COMBINATION TABLET VS CONCOMITANT ADMINISTRATION OF A CAPSULE CONTAINING RIFAMPICIN AND A TABLET CONTAINING ISONIAZID AND ETHAMBUTOL, Arzneimittel-Forschung, 45-2(11), 1995, pp. 1236-1239
AUTOMATED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF ACYCLOVIR IN PLASMA
Authors: SWART KJ HUNDT HKL GROENEWALD AM
Citation: Kj. Swart et al., AUTOMATED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF ACYCLOVIR IN PLASMA, Journal of chromatography, 663(1), 1994, pp. 65-69
PHARMACOKINETIC CHARACTERISTICS FOR EXTENT OF ABSORPTION AND CLEARANCE IN DRUG DRUG INTERACTION STUDIES/
Authors: SCHALL R HUNDT HKL LUUS HG
Citation: R. Schall et al., PHARMACOKINETIC CHARACTERISTICS FOR EXTENT OF ABSORPTION AND CLEARANCE IN DRUG DRUG INTERACTION STUDIES/, International journal of clinical pharmacology and therapeutics, 32(12), 1994, pp. 633-637
ABSOLUTE BIOAVAILABILITY OF A NEW HIGH-DOSE METHYLPREDNISOLONE TABLETFORMULATION
Authors: GROENEWOUD G HUNDT HKL LUUS HG MULLER FO SCHALL R
Citation: G. Groenewoud et al., ABSOLUTE BIOAVAILABILITY OF A NEW HIGH-DOSE METHYLPREDNISOLONE TABLETFORMULATION, International journal of clinical pharmacology and therapeutics, 32(12), 1994, pp. 652-654
RELATIVE BIOAVAILABILITY OF 4 CONTROLLED-RELEASE NIFEDIPINE PRODUCTS
Authors: SCHALL R MULLER FO HUNDT HKL DUURSEMA L GROENEWOUD G VANDYK M VANSCHALKWYK AMC
Citation: R. Schall et al., RELATIVE BIOAVAILABILITY OF 4 CONTROLLED-RELEASE NIFEDIPINE PRODUCTS, Biopharmaceutics & drug disposition, 15(6), 1994, pp. 493-503
INVESTIGATION OF A POSSIBLE PHARMACOKINETIC INTERACTION BETWEEN NISOLDIPINE AND QUINIDINE IN HEALTHY-VOLUNTEERS
Authors: SCHALL R MULLER FO GROENEWOUD G HUNDT HKL LUUS HG VANDYK M VANSCHALKWYK AMC
Citation: R. Schall et al., INVESTIGATION OF A POSSIBLE PHARMACOKINETIC INTERACTION BETWEEN NISOLDIPINE AND QUINIDINE IN HEALTHY-VOLUNTEERS, Drug investigation, 8(3), 1994, pp. 162-170
PHARMACOKINETIC PROFILE OF HIGH-DOSES OF APROTININ IN PATIENTS UNDERGOING PRIMARY ELECTIVE HYSTERECTOMY - A METAANALYSIS OF 2 CLINICAL-TRIALS
Authors: SCHALL R MULLER FO HUNDT HKL GROENEWOUD G OELOFSEN MJ UNGERER MJ WESSELS PH SCHUMANN F
Citation: R. Schall et al., PHARMACOKINETIC PROFILE OF HIGH-DOSES OF APROTININ IN PATIENTS UNDERGOING PRIMARY ELECTIVE HYSTERECTOMY - A METAANALYSIS OF 2 CLINICAL-TRIALS, Drug investigation, 7(4), 1994, pp. 200-208
PANTOPRAZOLE DOES NOT IMPAIR THE EFFICACY OF HORMONAL CONTRACEPTION
Authors: MIDDLE MV MULLER FO MOGILNICKA EM HUNDT HKL BENEKE PC SCHALL R STEINIJANS VW HARTMANN M BLIESATH H WURST W
Citation: Mv. Middle et al., PANTOPRAZOLE DOES NOT IMPAIR THE EFFICACY OF HORMONAL CONTRACEPTION, Gastroenterology, 106(4), 1994, pp. 10000139-10000139
THE H-ATPASE INHIBITOR PANTOPRAZOLE DOES NOT INFLUENCE THE PHARMACOKINETICS OF PHENYTOIN IN MAN(,K+)
Authors: MULLER FO BLIESATH H MIDDLE MV HUNDT HKL HARTMANN M SCHALL R STEINIJANS VW HUBER R WURST W
Citation: Fo. Muller et al., THE H-ATPASE INHIBITOR PANTOPRAZOLE DOES NOT INFLUENCE THE PHARMACOKINETICS OF PHENYTOIN IN MAN(,K+), Gastroenterology, 106(4), 1994, pp. 10000144-10000144
PANTOPRAZOLE DOES NOT INTERACT WITH WARFARIN IN MAN
Authors: MULLER FO MIDDLE MV DUURSEMA L HUNDT HKL SWART KJ SCHALL R LUUS HG BLIESATH H STEINIJANS VW WURST W
Citation: Fo. Muller et al., PANTOPRAZOLE DOES NOT INTERACT WITH WARFARIN IN MAN, Gastroenterology, 106(4), 1994, pp. 10000144-10000144
ANTITHROMBOTIC ACTIVITY OF BAY-U3405, A THROMBOXANE A(2)-ANTAGONIST, INPATIENTS WITH DACRON AORTIC GRAFTS - A RANDOM CONTROLLED CLINICAL-TRIAL
Authors: PIETERS H ROODT JP BADENHORST PN VANWYK V SCHALL R LOTTER MG HUNDT HKL NEL CJC
Citation: H. Pieters et al., ANTITHROMBOTIC ACTIVITY OF BAY-U3405, A THROMBOXANE A(2)-ANTAGONIST, INPATIENTS WITH DACRON AORTIC GRAFTS - A RANDOM CONTROLLED CLINICAL-TRIAL, Thrombosis and haemostasis, 70(6), 1993, pp. 903-908
STEADY-STATE PHARMACOKINETICS OF PHENTERMINE EXTENDED-RELEASE CAPSULES
Authors: GROENEWOUD G SCHALL R HUNDT HKL MULLER FO VANDYK M
Citation: G. Groenewoud et al., STEADY-STATE PHARMACOKINETICS OF PHENTERMINE EXTENDED-RELEASE CAPSULES, International journal of clinical pharmacology, therapy and toxicology, 31(8), 1993, pp. 368-372
Risultati: 1-25 | 26-28